Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed M Nurulain

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Applied Toxicology : JAT|July 3, 2019
Oximes as pretreatment before acute exposure to paraoxonDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Journal of Applied Toxicology : JAT|October 19, 2013
Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfoneDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Behavioural Brain Research|October 16, 2015
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in ratsNadia Khan, Ali Saad, Syed M Nurulain, et al.
International Journal of Molecular Sciences|April 3, 2021
Experimental and Established Oximes as Pretreatment before Acute Exposure to Azinphos-MethylDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Current Pharmaceutical Design|November 2, 2016
Optimal Pre-treatment for Acute Exposure to the Organophosphate DicrotophosDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Basic & Clinical Pharmacology & Toxicology|October 17, 2006
Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmineGeorg A Petroianu, Mohamed Y Hasan, Syed M Nurulain, et al.
Archives of Toxicology|November 22, 2013
Oxime-type acetylcholinesterase reactivators in pregnancy: an overviewSyed M Nurulain, Tekes Kornelia, Syed Naimul Hassan Naqvi, et al.
Journal of Molecular Neuroscience : MN|February 2, 2019
Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse DisorderSadaf Munir, Rabia Habib, Sliha Awan, et al.
Chemico-Biological Interactions|July 6, 2019
Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro modelsAmna Iqbal, Shahrukh Malik, Syed M Nurulain, et al.
Pancreas|April 16, 2015
Distribution of nociceptin in pancreatic islet cells of normal and diabetic ratsSaeed Tariq, Hameed Rashed, Syed M Nurulain, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Applied Toxicology : JAT|July 3, 2019
Oximes as pretreatment before acute exposure to paraoxonDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Journal of Applied Toxicology : JAT|October 19, 2013
Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfoneDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Behavioural Brain Research|October 16, 2015
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in ratsNadia Khan, Ali Saad, Syed M Nurulain, et al.
International Journal of Molecular Sciences|April 3, 2021
Experimental and Established Oximes as Pretreatment before Acute Exposure to Azinphos-MethylDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Current Pharmaceutical Design|November 2, 2016
Optimal Pre-treatment for Acute Exposure to the Organophosphate DicrotophosDietrich E Lorke, Syed M Nurulain, Mohamed Y Hasan, et al.
Basic & Clinical Pharmacology & Toxicology|October 17, 2006
Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmineGeorg A Petroianu, Mohamed Y Hasan, Syed M Nurulain, et al.
Archives of Toxicology|November 22, 2013
Oxime-type acetylcholinesterase reactivators in pregnancy: an overviewSyed M Nurulain, Tekes Kornelia, Syed Naimul Hassan Naqvi, et al.
Journal of Molecular Neuroscience : MN|February 2, 2019
Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse DisorderSadaf Munir, Rabia Habib, Sliha Awan, et al.
Chemico-Biological Interactions|July 6, 2019
Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro modelsAmna Iqbal, Shahrukh Malik, Syed M Nurulain, et al.
Pancreas|April 16, 2015
Distribution of nociceptin in pancreatic islet cells of normal and diabetic ratsSaeed Tariq, Hameed Rashed, Syed M Nurulain, et al.
Pageof 5